27-10-2021, 06:53 AM
Potential to be an EU first
If authorized, VLA2001 has the potential to be the first inactivated virus vaccine for Covid-19 in Europe. Authorised vaccines of this technology mainly cater to China (Sinopharm and Sinovac) or India (Bharat Biotech). Sinovac’s vaccine is in a rolling review with the EMA. Apart from preparing for its EMA submission, Valneva has an ongoing rolling submission with the UK.
We continue to believe that we will be able to make an important contribution to the global fight against the Covid-19 pandemic.
https://www.clinicaltrialsarena.com/news...facturing/
If authorized, VLA2001 has the potential to be the first inactivated virus vaccine for Covid-19 in Europe. Authorised vaccines of this technology mainly cater to China (Sinopharm and Sinovac) or India (Bharat Biotech). Sinovac’s vaccine is in a rolling review with the EMA. Apart from preparing for its EMA submission, Valneva has an ongoing rolling submission with the UK.
We continue to believe that we will be able to make an important contribution to the global fight against the Covid-19 pandemic.
https://www.clinicaltrialsarena.com/news...facturing/